Background In chronic kidney disease (CKD), increases in serum phosphate and parathyroid
hormone (PTH) aggravate vascular calcification (VC) and bone loss. This study was …

… disease and mortality in chronic kidney disease (CKD). … assess the associations between
serum phosphate, multiple … the associations between serum phosphate, multiple deprivation …

… Hence, our study shows that FGF23 normalizes serum phosphate and decreases 1,25-dihydroxyvitamin
D levels in early-stage CKD, and suggests a pathological sequence of events …

… without known kidney disease, each 1-mg/dl higher serum phosphate concentration was …
kidney function and no clinical cardiovascular disease, each 1-mg/dl higher serum phosphate …

… with and without chronic kidney disease (CKD). Even serum phosphate levels within the
normal range are associated with increased mortality, CVD and renal disease progression. …

… Hyperphosphatemia is a major risk factor for death, CVE, and vascular calcification
among patients with and without kidney disease. Even serum phosphate levels within the “normal …

… serum phosphate with progression of the kidney disease itself.10-14 In view of all of these
considerations, adequate control of serum phosphate is … between serum phosphate levels and …

… changes in serum phosphate and FGF23 levels after kidney … ENdothelial FuNction in Chronic
KidneY Disease (PENNY) … activated Vitamin D increase serum phosphate and FGF23 in …

… Serum phosphate levels and mortality risk among people with chronic kidney disease, J
Am … High plasma phosphate as a risk factor for decline in renal function and mortality in pro-…

… Third Health and Nutrition Examination Survey populations, elevation of serum alkaline
phosphatase and serum phosphate together conferred greater risk than either parameter alone. …